Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Adena

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
American Journal of Epidemiology|May 1, 1987
Mortality among Australian conscripts of the Vietnam conflict era. II. Causes of deathM J Fett, J R Nairn, D M Cobbin, et al.
Clinical Therapeutics|April 2, 1998
Risperidone versus haloperidol: I. Meta-analysis of efficacy and safetyA Davies, M A Adena, N A Keks, et al.
Lancet (London, England)|September 16, 1989
Smoking as a risk factor for cerebral ischaemiaG A Donnan, J J McNeil, M A Adena, et al.
Acta Neurologica Scandinavica|December 1, 1995
Age at onset: the major determinant of outcome in Parkinson's diseaseM A Hely, J G Morris, W G Reid, et al.
The Medical Journal of Australia|December 9, 1985
Mortality among Vietnam veterans compared with non-veterans and the Australian populationM A Adena, D M Cobbin, M J Fett, et al.
The Journal of Rheumatology|January 1, 1988
Dose response studies and longterm evaluation of auranofin in rheumatoid arthritisG D Champion, D R Cairns, D Bieri, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
American Journal of Epidemiology|May 1, 1987
Mortality among Australian conscripts of the Vietnam conflict era. II. Causes of deathM J Fett, J R Nairn, D M Cobbin, et al.
Clinical Therapeutics|April 2, 1998
Risperidone versus haloperidol: I. Meta-analysis of efficacy and safetyA Davies, M A Adena, N A Keks, et al.
Lancet (London, England)|September 16, 1989
Smoking as a risk factor for cerebral ischaemiaG A Donnan, J J McNeil, M A Adena, et al.
Acta Neurologica Scandinavica|December 1, 1995
Age at onset: the major determinant of outcome in Parkinson's diseaseM A Hely, J G Morris, W G Reid, et al.
The Medical Journal of Australia|December 9, 1985
Mortality among Vietnam veterans compared with non-veterans and the Australian populationM A Adena, D M Cobbin, M J Fett, et al.
The Journal of Rheumatology|January 1, 1988
Dose response studies and longterm evaluation of auranofin in rheumatoid arthritisG D Champion, D R Cairns, D Bieri, et al.
Pageof 2